Related Experiment Videos
[Israel national childhood acute lymphoblastic leukemia study]
1Pediatric Hematology-Oncology Dept., Beilinson Medical Center, Petah Tikva, Jerusalem.
Harefuah
|April 1, 1990
Summary
This study on childhood acute lymphoblastic leukemia (ALL) found that intrathecal triple therapy is as effective as cranial irradiation for CNS prophylaxis. Intensive chemotherapy improved leukemia-free survival, especially in high-risk groups.
Area of Science:
- Pediatric Oncology
- Hematology
- Clinical Trials
Context:
- Childhood acute lymphoblastic leukemia (ALL) presents treatment challenges, including high-risk groups, late relapses, and CNS prophylaxis sequelae.
- Cranial irradiation for CNS prophylaxis can lead to late neuropsychiatric issues and secondary tumors.
Purpose:
- To improve treatment outcomes for childhood ALL, focusing on high-risk patients, late relapses, and CNS prophylaxis side effects.
- To evaluate the efficacy of intrathecal (IT) triple therapy as an alternative to cranial irradiation for CNS prophylaxis in ALL.
Summary:
- A national study in Israel (1984-1989) enrolled 143 childhood ALL patients, testing intensified chemotherapy and comparing IT triple therapy with cranial irradiation for CNS prophylaxis.
- Results showed 4-year leukemia-free interval (LFI) and event-free interval (EFI) of 60% and 57%, respectively.
- Intrathecal triple therapy demonstrated comparable efficacy to cranial irradiation for CNS prophylaxis in standard-risk ALL, with fewer CNS relapses.
Impact:
- Intrathecal triple therapy is a viable alternative to cranial irradiation for CNS prophylaxis in childhood ALL, warranting its use in higher-risk groups.
- Intensified upfront chemotherapy is recommended for all ALL groups, with dose adjustments to minimize long-term adverse effects.
- The study provides valuable data on treatment strategies and outcomes for childhood ALL, contributing to improved patient management.